Lidia Fonseca - 23 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role: Executive Vice President
Signature: Susan E. Grant, by power of atty., for Lidia Fonseca
Issuer symbol: PFE
Transactions as of: 23 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 24 Feb 2023, 19:22:50 UTC
Previous filing: 30 Jun 2022
Next filing: 03 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PFE	Common Stock						35,754	23 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+43,624		$0.000000	43,624	23 Feb 2023	Common Stock	43,624	$42.30	Direct	F1
transaction	PFE	Stock Appreciation Rights	Award	$0	+37,966		$0.000000	37,966	23 Feb 2023	Common Stock	37,966	$42.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F2	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.